Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATORVASTATIN CALCIUM (USP) CRYSTALLINE, with a corresponding US DMF Number 25247.
Remarkably, this DMF maintains an Active status since its submission on August 26, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 18, 2014, and payment made on April 15, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II